Skip to content

A Randomized Controlled Study for Safety Assessment of Ambulatory Surgery of papillary thyroid carcinoma

A Randomized Controlled Study for Safety Assessment of Ambulatory Surgery of papillary thyroid carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023722
Enrollment
Unknown
Registered
2019-06-09
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

papillary thyroid carcinoma

Interventions

original surgery:original inpatient surgery
ambulatory surgery:ambulatory surgery

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Gender is not limited, but the number of men and women is equal. 2) Aged 18-60 years. 3) Before the operation, the subjects were willing and able to sign the informed consent approved by the Institutional Review Board (IRB), the Ethics Committee (EC) or the Ethics Review Board (ERB). 4) According to the judgement of clinical researchers, the subjects can understand the clinical research and cooperate with the research process. 5) Initial operation. 6) Admission diagnosis of "papillary thyroid carcinoma"(confirmed by FNA) 7) Preoperative cervical lymph node non-metastasis (cN0) and no distant metastasis

Exclusion criteria

Exclusion criteria: 1) Subjects could not provide written consent for voluntary participation in clinical research. 2) Eliminate chronic diseases, severe liver and kidney insufficiency, acute infectious diseases, autoimmune diseases, malignant tumors and other diseases. 3) Subjects had alcoholism or drug addiction and/or mental illness, and the researchers thought it might affect their participation in this study. 4) Subjects have diseases that restrict their participation in this study, fail to comply with follow-up requirements or affect the scientific integrity of the study. 5) Subjects are currently participating in another experimental drug or device study. 6) Preoperative local invasion such as trachea, esophagus, recurrent laryngeal nerve or cervical great vessels 7) Ambulatory surgery is not allowed because of cardiopulmonary insufficiency or any other reason.

Design outcomes

Primary

MeasureTime frame
morbidity incidence;readmission rate within 30 days;

Secondary

MeasureTime frame
Hospitalization expenses;Intraoperative blood loss;Hospitalization Days;

Countries

China

Contacts

Public ContactXinying Li

Xiangya Hospital, Central South University

lixinyingcn@126.com+86 13755110832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026